SOURCE: Innovation Institute for Fan Experience
Board will provide guidance on the evolving science of COVID-19 and future health threats to members of the sports and entertainment industry
April 7, 2021 Jackson, Mississippi – The Innovation Institute for Fan Experience (IIFX) has announced formation of a new Medical Advisory Board – IIFX MD -- to provide industry thought leadership focused on science-driven best practices for venues, participants and fans.
|
Dr. Til Jolly, Chief Medical Officer of Aveshka, Inc. will lead IIFX MD Medical Advisory Board. |
The Board will work closely with IIFX Founder, Dr. Lou Marciani, the IIFX Distinguished Fellows, and other international industry leaders and will be chaired by Dr. Til Jolly, IIFX Distinguished Fellow and Chief Medical Officer of Aveshka, Inc.
“This board includes medical advisers for some of the world’s most prominent professional organizations and teams. We are pleased that such a distinguished group has agreed to serve in this vital role for our industry,” said Dr. Marciani. “They have the experience and knowledge to weigh in and lead us forward on some of the industry’s most pressing medical topics.”
Named to the Advisory Board are the following medical professionals:
Mike Patterson, MD, FRCEM, FFICM - Attending Emergency Physician and Intensivist and Chief Medical Officer for Venues, Events and Emergency Care at The Football Association (England)
Amie Kim, MD, CAQSM - Assistant Professor of Emergency Medicine and Physical Medicine and Rehabilitation; Mount Sinia Hospital Icahn School of Medicine in New York City; and Physician Adviser to the NBA, NFL’s New York Jets, and USTA US Open
Thom Mayer, MD, FACEP, FAAP, FACHE – Medical Director for the NFL Players Association; a Medical Director for Studer Group; Clinical Professor of Emergency Medicine at George Washington University; and Senior Lecturing Fellow at Duke University
Charles Branas, PhD – Gelman Endowed Professor and Chair, Department of Epidemiology, Columbia University Mailman School of Public Health; and Member of the National Academy of Medicine
TK Miller, MD – Chairman, IRONMAN Global Medical Advisory Board; and Vice Chairman, Department of Orthopedic Surgery, Carilion Clinic, Roanoke, VA
Robert Nied, MD – Chief Medical Officer, Golden State Warriors
Pranav Kothari, MD – Chief Medical Officer, Rock Family of Companies, Detroit MI
Til Jolly, MD FACEP – Chief Medical Officer, Aveshka, Inc.; Clinical Professor of Emergency Medicine, The George Washington University; and Senior Consultant, Department of Health and Human Services
The IIFX Medical Advisory Board will work with the IIFX leadership team to foster best practices and education for venues, participant, and fans who are striving to work, play, and spectate safely and effectively.
“We encourage industry members and leaders to share with IIFX any topics or emerging medical related challenges your organization might be facing," added Marciani. Please Email Marciani@IIFX.org or call us at 1-(601)-909-4439 to share topics of concern for the Advisory Board.
The Board has begun the sponsorship of a weekly “COVID Risk Playbook Health and Medical” Podcast series, bringing together a wide range of experts to discuss and share knowledge of critical COVID topics, including youth and mental health, vaccines, performance athletics, and a host of other issues. The podcast series can be found at https://iifx.org/podcasts/ or can be listened to on Apple Podcasts, Spotify, Google Podcasts, and at https://aveshka.com/podcasts-and-webinars/.
About the Innovation Institute for Fan Experience
Founded in 2020 in the midst of the pandemic by veteran industry leaders, IIFX’s vision is to be the leading and most trusted global authority on providing safety, security and fan experience for sports and entertainment. With offices in the USA, UK and Canada, IIFX produces content, events, and facilitates dialogue and collaboration in the sports and entertainment industry around its core areas of expertise. Visit: iifx.org for more.
About Dr. Lou Marciani: Read more at this link.
